Aldeyra Therapeutics, Inc. — Form D

Aldeyra Therapeutics, Inc. of LEXINGTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-03. The offering totals $8.8M, of which $4.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Ben BronsteinDirectorWestborough, MA
Gerald CagleDirectorFort Worth, TX
John DowlingDirectorBurlington, MA
Gary PhillipsDirectorNewton, MA
Asish XavierDirectorSouth San Francisco, CA
Gerald CagleExecutive OfficerFort Worth, TX
Todd BradyDirectorAtlanta, GA
Todd BradyExecutive OfficerAtlanta, GA
David L ClarkExecutive OfficerFortville, IN
Richard I DouglasDirectorLexington, MA
Neal J WalkerDirectorLexington, MA
Martin J JoyceDirectorLexington, MA
Ben J BronsteinDirectorLexington, MA
David L McMullinExecutive OfficerLexington, MA
Gary J PhillipsDirectorLexington, MA
Stephen I MachathaExecutive OfficerLexington, MA
Joshua ReedExecutive OfficerLexington, MA
Todd C BradyDirectorCRANBURY, NJ
Todd C BradyExecutive OfficerCRANBURY, NJ
Stephen C TulipanoExecutive OfficerLexington, MA
Scott C YoungExecutive OfficerLexington, MA
C.Boyd C ClarkeDirectorLexington, MA
Scott L YoungExecutive OfficerLexington, MA
C. Boyd L ClarkeDirectorLexington, MA
Jesse I TreuDirectorPrinceton, NJ

Other filings by this issuer (3)

FiledFormOfferingSold
2019-02-11D$25.0M$10.0M
2015-02-05D$4.0M$2.0M
2015-01-29D$18.4M$7.8M

More